Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution.
Combinatorial library selections through the systematic evolution of ligands by exponential enrichment (SELEX) technique identify so-called nucleic acid aptamers that bind with high-affinity and specificity to a wide range of selected molecules. However, the modest chemical functionality of nucleic acids poses some limits on their versatility as binders and catalysts, and, furthermore, the sensitivity of pure RNA- and DNA-based aptamers to nucleases restricts their use as therapeutic and diagnostic agents. Here we review synthetic chemistries for modifying nucleotides that have been developed to enhance the affinity of aptamers for targets and to increase their stability in biological fluids. Implementation of in vitro selections with modified nucleotides promises to be an elegant technique for the creation of ligands with novel physical and chemical properties and is anticipated to have a significant impact on biotechnology, diagnostics and drug development. The current molecular designs and applications of modified nucleotides for in vitro selections are reviewed, along with a discussion of future developments expected to further the utility of this approach in both practical and theoretical terms.
Kusser
W
W
Invitrogen Corporation, Carlsbad, CA 92008, USA. wkusser@invitrogen.com
D000818:Animals; D020650:Combinatorial Chemistry Techniques; D004277:DNA, Single-Stranded / Q000737:chemistry* / Q000378:metabolism; D019020:Directed Molecular Evolution / Q000379:methods*; D006801:Humans; D009841:Oligonucleotides / Q000737:chemistry* / Q000378:metabolism
D004277:DNA, Single-Stranded; D009841:Oligonucleotides